LifePlan Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$868K Buy
3,420
+186
+6% +$43.3K 0.3% 75
2026
Q1
$791K Sell
3,234
-21
-0.6% -$4.89K 0.31% 76
2025
Q4
$674K Buy
3,255
+160
+5% +$31.6K 0.27% 71
2025
Q3
$574K Buy
3,095
+164
+6% +$28.1K 0.24% 74
2025
Q2
$448K Buy
2,931
+63
+2% +$9.68K 0.22% 72
2025
Q1
$476K Hold
2,868
0.27% 70
2024
Q4
$415K Sell
2,868
-21
-0.7% -$3.25K 0.26% 68
2024
Q3
$468K Buy
2,889
+27
+0.9% +$4.3K 0.3% 59
2024
Q2
$418K Sell
2,862
-106
-4% -$15.8K 0.3% 57
2024
Q1
$470K Buy
2,968
+16
+0.5% +$2.55K 0.37% 53
2023
Q4
$463K Sell
2,952
-141
-5% -$21.6K 0.42% 43
2023
Q3
$482K Buy
+3,093
New +$510K 0.51% 37

Other funds holding JNJ

LifePlan Investment Advisors's JNJ Position: Q2 2026 in Review

LifePlan Investment Advisors increased its Johnson & Johnson (JNJ) stake by 5.8% in Q2 2026, buying an estimated $43.3K and bringing the position to 3,420 shares worth $868K. The position accounts for 0.3% of the portfolio, ranked #75.

LifePlan Investment Advisors first reported a position in JNJ in Q3 2023 and has held it in 12 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • LifePlan Investment Advisors held 3,420 shares of Johnson & Johnson worth $868K as of Q2 2026.
  • LifePlan Investment Advisors bought 186 Johnson & Johnson shares in Q2 2026, an estimated $43.3K.
  • Johnson & Johnson made up 0.3% of LifePlan Investment Advisors's portfolio in Q2 2026, its #75 holding.
  • LifePlan Investment Advisors first reported a position in Johnson & Johnson in Q3 2023 and has held it in 12 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on LifePlan Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.